Edward Mead Johnson

Born in 1853 as the youngest of the three Johnson brothers, Edward Mead Johnson co-founded Johnson & Johnson in 1886 before eventually departing to pursue his own commercial interests in infant nutrition — a decision that would lead him to found Mead Johnson and Company, the nutritional products business that remained a significant enterprise for more than a century before being acquired by Bristol-Myers Squibb and later by Reckitt Benckiser. His departure from J&J was entrepreneurially motivated rather than conflictual, and the Mead Johnson legacy represents one of the more unusual cases of a co-founder's post-departure enterprise outlasting his co-founded company's original product category.

Edward Mead Johnson's tenure at Johnson & Johnson was the shortest of the three brothers, but his departure to pursue the infant nutrition and pediatric dietary supplement market established a separate commercial legacy that endured for well over a century. Mead Johnson, the company he founded after leaving J&J, developed nutritional formulas for infants and young children at a time when pediatric nutrition science was in its early development — a category that grew substantially through the twentieth century as infant formula adoption expanded globally and nutritional science generated evidence for specific dietary requirements in pediatric development. Edward Mead Johnson's commercial instinct for pediatric health needs represented an extension of the broader Johnson family interest in healthcare products for vulnerable populations — an interest that J&J itself would also develop through the Johnson's Baby product line that became one of its most globally recognized consumer franchises. The Mead Johnson business eventually became part of Bristol-Myers Squibb before being acquired by Reckitt Benckiser in 2017 for approximately $16.6 billion, demonstrating the enduring commercial value of the pediatric nutrition platform that Edward built from his post-J&J entrepreneurial departure.